Wall Street analysts covering Biogen Idec Inc. (NASDAQ:BIIB) shares are predicting that the stock will trade between $283 and $386 within the next year. This is the top price point and lowest from the analysts taken …
Bull Run
Biogen Inc (NASDAQ:BIIB), a company with a decent past earnings performance and future growth potential, is currently trading at a PE multiple of 16, below the industry average of 37.2. See our latest analysis for BIIB
Wall Street
Biogen Idec Inc. (BIIB) stock price can appreciate to the mid $70s based on five areas of potential upside, according to RBC Capital Markets. The brokerage upgraded its rating on shares of the biotechnology company …
In reaction to the CTAD abstracts that have investors excited, the analyst reiterates an Overweight rating on …
Divided
Benjamin Graham taught that Intelligent Investors must do a thorough fundamental analysis of investment opportunities to determine their intrinsic value and inherent risk. This is best done by utilizing a systematic …
Tina provides the U.S. as well as global markets commentary that cover the stock, commodity, and currency markets. She covers latest activity, events and trends, from economic reports and financial indicators relating …
Biogen Idec Inc (Nasdaq:BIIB) hit a new 52-week high Monday as it is currently trading at $109.69, above its previous 52-week high of $109.63 with 1.7 million shares traded as of 2:55 p.m. ET. Average volume has been …
A stock experiencing a high level of volatility has a higher ... The high …
America Corp